Nov 13 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* Valeant announces launch of private offering of add-on secured notes
* Valeant - launched offering of $750 million aggregate principal amount of 5.500% senior secured notes due 2025
* Valeant - new notes will be additional notes and form part of same series as Valeant's existing 5.500% senior secured notes due 2025
* Valeant - intends to use proceeds from offering to repay a portion of its outstanding series F tranche B term loan facilities due 2022